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Abstract
Nicotinic receptors are not only expressed by excitable tissues, but have been
identified in various epithelia. One aim of this study was to investigate the expres-
sion of nicotinic receptors and their involvement in the regulation of ion trans-
port across colonic epithelium. Ussing chamber experiments with putative
nicotinic agonists and antagonists were performed at rat colon combined with
reverse transcription polymerase chain reaction (RT-PCR) detection of nicotinic
receptor subunits within the epithelium. Dimethylphenylpiperazinium (DMPP)
and nicotine induced a tetrodotoxin-resistant anion secretion leading to an
increase in short-circuit current (Isc) across colonic mucosa. The response was
suppressed by the nicotinic receptor antagonist hexamethonium. RT-PCR experi-
ments revealed the expression of a2, a4, a5, a6, a7, a10, and b4 nicotinic receptor
subunits in colonic epithelium. Choline, the product of acetylcholine hydrolysis,
is known for its affinity to several nicotinic receptor subtypes. As a strong acetyl-
cholinesterase activity was found in colonic epithelium, the effect of choline on Isc
was examined. Choline induced a concentration-dependent, tetrodotoxin-resis-
tant chloride secretion which was, however, resistant against hexamethonium, but
was inhibited by atropine. Experiments with inhibitors of muscarinic M1 and M3
receptors revealed that choline-evoked secretion was mainly due to a stimulation
of epithelial M3 receptors. Although choline proved to be only a partial agonist, it
concentration-dependently desensitized the response to acetylcholine, suggesting
that it might act as a modulator of cholinergically induced anion secretion. Thus
the cholinergic regulation of colonic ion transport – up to now solely explained
by cholinergic submucosal neurons stimulating epithelial muscarinic receptors –
is more complex than previously assumed.
Abbreviations
DMPP, dimethylphenylpiperazinium; DMSO, dimethylsulfoxide; EDTA, ethylene-
diaminotetraacetic acid; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; Gt,
tissue conductance; Isc, short-circuit current; RT-PCR, reverse transcription poly-
merase chain reaction; TTX, tetrodotoxin.
Introduction
Acetylcholine, produced by enteric neurons (e.g., Harring-
ton et al. 2010) as well as by the colonic epithelium
(Klapproth et al. 1997; Bader et al. 2014) is a central reg-
ulator of many gastrointestinal functions. The actions of
this transmitter are mediated either by muscarinic or nic-
otinic receptors. Muscarinic receptors are metabotropic,
G-protein-coupled receptors with five subtypes (M1–M5).
The muscarinic receptors M2 and M4 couple to the Gia
subunit and thus inhibit the adenylate cyclase, whereas
M1, M3, and M5 couple to Gq/11a subunits. The subse-
quent activation of phospholipase C leads to stimulation
of protein kinase C and increased levels of the cytosolic
Ca2+ concentration (Hirota and McKay 2006). Muscarinic
receptors are widely expressed in the alimentary tract.
The M1 subtype has been shown to localize on enteric
neurons (Khan et al. 2013), on intestinal glands (Wessler
ª 2015 The Authors. Pharmacology Research & Perspectives published by John Wiley & Sons Ltd,
British Pharmacological Society and American Society for Pharmacology and Experimental Therapeutics.
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License,
which permits use, distribution and reproduction in any medium, provided the original work is properly cited and
is not used for commercial purposes.
2015 | Vol. 0 | Iss. 0 | e00139
Page 1
and Kirkpatrick 2008) as well as on colonic epithelial cells
(Haberberger et al. 2006; Wessler and Kirkpatrick 2008;
Khan et al. 2013), whereas the M3 subtype is localized on
the epithelium (Hirota and McKay 2006; Wessler and
Kirkpatrick 2008).
In contrast, nicotinic receptors are homo- or hetero-
pentamers enclosing an ion channel, that is, they function
as ionotropic receptors. Until now, the following subunits
have been identified in vertebrates: 10 a subunits (a1–
a10), four b subunits (b1–b4), one c subunit, one d sub-
unit, and one e subunit. They were classified into neuro-
nal-type and muscle-type nicotinic receptors (Schuller
2009). The neuronal nicotinic receptors are either homo-
mers consisting of five identical a7, (a8), or a9 subunits
or they are heteropentamers consisting of combinations
of a2–a6 or a10 subunits with b2–b4 subunits (Schuller
2009). The muscle nicotinic receptors are comprised of
two a1 subunits in combination with b1, c, and e in adult
skeletal muscle (Kalamida et al. 2007).
However, the expression of nicotinic receptors is not
restricted to excitable tissues such as nerves or skeletal
muscle, they were also found in epithelia of, for example,
placenta (Lips et al. 2005), trachea (Kummer et al.
2008), urinary bladder (Haberberger et al. 2002; Beckel
2005), and skin (for review see Wessler and Kirkpatrick
2008). There is evidence that epithelial nicotinic recep-
tors are involved in tumorgenesis in the respiratory and
the gastrointestinal tract (Schuller 2009; Improgo et al.
2013). Although there are hints for the expression of nic-
otinic receptors in colonic epithelium, there is no study
about the distribution of nicotinic receptor subunits in
native colonic epithelial cells. Furthermore, it remains
unclear whether nicotinic receptors are involved in the
regulation of colonic ion transport, one of the funda-
mental functions of this tissue. Therefore, in this study,
we investigated the expression of nicotinic receptor su-
bunits in isolated colonic crypts and the effect on ion
secretion of presumed nicotinic agonists across rat distal
colon.
Materials and Methods
Animals
Female and male Wistar rats with a body mass of 160–
240 g were used. The animals were bred and housed at
the Institute of Veterinary Physiology and Biochemistry
of the Justus-Liebig-University at an ambient temperature
of 22.5°C and air humidity of 50–55% on a 12:12 h light-
dark cycle with free access to water and food until the
time of the experiment. Animals were stunned by a blow
on the head and killed by exsanguination (approved by
Regierungspr€asidium Giessen, Germany).
Solutions
If not indicated differently (e.g., in ion substitution exper-
iments), all Ussing chamber experiments were carried out
in a bathing solution containing (in mmol/L): 107 NaCl,
4.5 KCl, 25 NaHCO3, 1.8 Na2HPO4, 0.2 NaH2PO4, 1.25
CaCl2, 1 MgSO4, and 12.2 glucose. The solution was
gassed with 5% (v/v) CO2 and 95% (v/v) O2 at 37°C and
had a pH of 7.4 (adjusted by NaHCO3/HCl). For the
Cl-free buffer, NaCl and KCl were equimolarly substi-
tuted by Na gluconate (NaGluc) and K gluconate
(KGluc), respectively. To obtain a Ca2+-free buffer, CaCl2
was omitted from the buffer without additional adminis-
tration of a Ca2+-chelating agent.
For crypt isolation, a Ca2+- and Mg2+-free Hanks bal-
anced salt solution containing 10 mmol/L ethylenediami-
notetraacetic acid (EDTA) was used. The pH was
adjusted to 7.4 by tris(hydroxymethyl)-aminomethane.
The isolated crypts were stored in a high potassium Ty-
rode solution consisting of (in mmol/L): 100 K gluconate,
30 KCl, 20 NaCl, 1.25 CaCl2, 1 MgCl2, 10 HEPES, 12.2
glucose, 5 Na pyruvate, and 1 g/L bovine serum albumin;
pH was 7.4 (adjusted by KOH). Tissue was fixed in
100 mmol/L phosphate buffer (pH 7.4) containing 40 g/L
paraformaldehyde. For the histochemical staining of ace-
tylcholinesterase activity, a citrate buffer (100 mmol/L,
pH 5.0) was used containing (in mmol/L) 2.5 CuSO4, 5
K3[Fe(CN)6], and 1 acetylthiocholine chloride. For the
rehydration of the colon sections, a 100 mmol/L sodium-
hydrogen maleate buffer (pH 6.0) was used.
Tissue preparation
The distal colon was quickly removed and placed in ice-
cold Ussing chamber bathing solution. The colon was
mounted on a thin plastic rod. A circular incision was
made near the distal end with a blunt scalpel. The serosa
and muscularis propria were stripped off to obtain a
mucosa–submucosa preparation. This preparation was
either directly used for Ussing chamber experiments or
for the preparation of the mucosa. For the latter, the
mucosa–submucosa was opened along the mesenteric
border and placed onto a glass plate. The proximal end
of the tissue was clamped with a clip. The distal end of
the colon was fixed with another slide. With a sharp
glass slide the mucosa was carefully separated from the
submucosal layer in order to obtain a mucosa prepara-
tion.
Ussing chamber experiments
Either mucosa preparations (for the experiments with
nicotine) or mucosa–submucosa preparations (for the
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experiments with choline) were fixed in a modified Us-
sing chamber, bathed with a volume of 3.5 mL on each
side of the mucosa. The tissue was incubated at 37°C
and short-circuited by a computer-controlled voltage-
clamp device (Ingenieur B€uro f€ur Mess- und Datentech-
nik Mussler, Aachen, Germany) with correction for solu-
tion resistance. Tissue conductance (Gt) was measured
every minute by the voltage deviation induced by a cur-
rent pulse (50 lA, duration 200 msec) under open-cir-
cuit conditions. Short-circuit current (Isc) was
continuously recorded. Isc is expressed as lEq/h per
cm2, that is, the flux of a monovalent ion per time and
area, with 1 lEq/h per cm2 = 26.9 lA/cm2. All drugs
were administered to the serosal side of the tissue. The
maximal increase in Isc evoked by an agonist is given as
difference to the baseline just prior administration of
the drug.
Isolation of RNA from intact colonic crypts
The colon was rinsed with Hank’s balanced salt solution.
The mucosa–submucosa preparation was fixed on a plas-
tic holder with tissue adhesive and transferred for 6 min
to Hank’s-EDTA solution. The tissue was vibrated for
30 sec in order to release crypts. This results in a pure
preparation of viable crypts which have been intensively
used for electrophysiological or imaging experiments
(Schultheiss et al. 2002).
Crypts were collected in a high potassium Tyrode and
centrifuged 3 min at 1000 g. Total RNA was isolated
from the pellet using the NucleoSpin RNA kit (Mache-
rey-Nagel, D€uren, Germany) according to the manufac-
turer’s protocol. Contaminating DNA was digested by
rDNase (provided with the latter kit).
Reverse transcriptase polymerase chain
reaction experiments
RNA was reverse transcribed with Tetro cDNA synthesis
kit (Bioline, Luckenwalde, Germany) or with Superscript
II cDNA synthesis kit (Life Technologies, Darmstadt,
Germany). For subsequent reverse transcription polymer-
ase chain reaction (RT-PCR) with the primer pairs (Eu-
rofins Genomics, Ebersberg, Germany) listed in Table 1,
MangoMixTM mastermix (Bioline, Luckenwalde, Ger-
many) was used with 2.5 mmol/L MgCl2. Due to higher
sensitivity, a touchdown PCR was performed. For a1, a2,
a3, a4, a5, a6, a9, a10, b2, and b3 cycling conditions
were: after an initial denaturation for 10 min at 95°C, 10
cycles were run with of 95°C for 45 sec, annealing for
45 sec with an initial temperature of 67°C (decreasing by
1°C per cycle), and 72°C for 45 sec. This was followed
by 30 cycles of 95°C for 45 sec, 57°C for 45 sec, 72°C
for 45 min, with a final extension at 72°C for 7 min.
For a7, b1, b4 cycling conditions were: after an initial
denaturation for 10 min at 95°C, 10 cycles were run
with of 95°C for 45 sec, annealing for 45 sec with an
initial temperature of 71°C (decreasing by 1°C per
cycle), and 72°C for 45 sec. This was followed by 30
cycles of 95°C for 45 sec, 61°C for 45 sec, 72°C for
45 min, with a final extension at 72°C for 7 min. For
M1 and M3 receptors cycling conditions were as follows:
after an initial denaturation for 3 min at 95°C, 10 cycles
were run with of 95°C for 45 sec, annealing for 45 sec
with an initial temperature of 65°C (decreasing by 1°C
per cycle), and 72°C for 60 sec. This was followed by 30
cycles of 95°C for 45 sec, 55°C for 45 sec, 72°C for
60 sec, with a final extension at 72°C for 10 min. For an
internal control of the PCR reaction, glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) was used. PCR
products were visualized after electrophoresis in a 2.5%
(w/v) agarose gel (Peqlab, Erlangen, Germany) with Gel-
RedTM (Biotium, Hayward, CA) or Roti-GelStain (Roth,
Karlsruhe, Germany).
Enzyme-histochemical detection of
acetylcholinesterase activity
In order to locate acetylcholinesterase activity in rat colo-
nic epithelium, we used the method of Karnovky and
Roots (1964) with slight modifications (Tsuji and Larabi
1983). This method employs acetylthiocholine as a sub-
strate for acetylcholinesterase. The cleavage product of the
esterase activity, thiocholine, reduces ferricyanide to ferro-
cyanide and this in turn is precipitated by Cu2+ as copper
ferrocyanide.
Distal colon was fixed with 40 g/L paraformaldehyde
in phosphate buffer at 4°C overnight. After washing
three times in phosphate buffer, the tissue was embed-
ded in gelatin and cryofixed with N2-cooled isopentane.
Sections (about 6 lm thick) were mounted on glass
slides coated with gelatin containing chromium(III)
potassium sulfate (0.5 g/L). After rehydration in maleate
buffer, the sections were incubated with the incubation
medium overnight at 4°C. The sections were rinsed in
maleate buffer again (four times for 2 min) and subse-
quently coverslipped. As negative control, other sections
were incubated in a medium without acetylthiocholine
chloride.
Drugs
Bumetanide and forskolin were dissolved in ethanol (final
maximal volume concentration of ethanol 2.5 mL/L).
Calmidazolium, darifenacin, J104129 (Tocris, Bristol,
UK), and trifluoperazine were dissolved in dimethylsulf-
ª 2015 The Authors. Pharmacology Research & Perspectives published by John Wiley & Sons Ltd,
British Pharmacological Society and American Society for Pharmacology and Experimental Therapeutics.
2015 | Vol. 0 | Iss. 0 | e00139
Page 3
S. Bader & M. Diener Cholinergic Regulation of Colonic Ion Transport
oxide (DMSO; final maximal DMSO volume concentra-
tion 2.5 mL/L). Tetrodotoxin was dissolved in
2 9 102 mol/L citrate buffer. Acetylcholine chloride, acet-
ylthiocholine chloride, atropine, a-bungarotoxin (Tocris),
carbachol, choline, dihydro-b-erythroidine (Tocris),
DMPP, hexamethonium, nicotine hydrogen tartrate, pire-
nzepine, strychnine, and telenzepine were dissolved in dis-
tilled water. If not indicated differently, drugs were
purchased from Sigma, Taufkirchen, Germany.
Statistics
Results are given as mean  standard error of the mean
(SEM) with the number (n) of investigated tissues. For the
comparison of two groups either Student’s t-test or Mann–
Whitney-U-test was applied. An F-test decided which test
method had to be used. Both paired and unpaired two-
tailed Student’s t-tests were applied as appropriate.
P < 0.05 was considered to be statistically significant.
Table 1. Primers used for RT-PCR.
Sequence Product length Accession no. Reference
a1
Forward AACTTCATGGAGAGCGGAGA 285 NM_024485 Schirmer et al. (2011)
Reverse CAGCTCCACAATGACGAGAA
a2
Forward CTTCGGTGAAGGAAGACTGG 154 L 10077 Lips et al. (2005)
Reverse GGAGCCAACATGAAGGACAT
a3
Forward GCCAACCTCACAAGAAGCTC 208 NM_052805 Schirmer et al. (2011)
Reverse CCAGGATGAAAACCCAGAGA
a4
Forward GACTTTGCAGTCACCCACCT 197 M 15682 Lips et al. (2005)
Reverse CGGCTATGCATGCTCACTAA
a5
Forward ACCCTACCAATTTGCAACCA 146 J 05231 Lips et al. (2005)
Reverse GACCCAAAGACCCATTCTGA
a6
Forward TGGTGTTAAGGACCCCAAAA 142 L 08227 Lips et al. (2005)
Reverse GCTGCTGGCTTAACCTCTTG
a7
Forward GGAGGCTGTACAAGGAGCTG 446 L 31619 Lips et al. (2005)
Reverse ACCCTCCATAGGACCAGGAC
a10
Forward TCTGACCTCACAACCCACAA 168 AF 196344 Lips et al. (2005)
Reverse TCCTGTCTCAGCCTCCATGT
b1
Forward TCCTAAGCGTGGTGGTCCTC 151 NM_012528 Mikulski et al. (2010)
Reverse TGTGGTTCGGGTAGTTGGTC
b2
Forward AGCCTTCTTTGGCTGTGCTC 116 NM_019297 Mikulski et al. (2010)
Reverse GAGCCGTTAGTAGCTGGACGA
b3
Forward CACTCTGCGCTTGAAAGGAA 196 NM_133597 Mikulski et al. (2010)
Reverse GCGGACCCATTTCTGGTAAC
b4
Forward ATGAAGCGTCCCGGTCTTGAAGTC 300 NM_052806 Liu et al. (2004)
Reverse GGTCATCGCTCTCCAGATGCTGGG
M1
Forward GCACAGGCACCCACCAAGCAG 373 M16406 Wei et al. (1994)
Reverse AGAGCAGCAGCAGGCGGAACG
M3
Forward GTCTGGCTTGGGTCATCTCCT 434 M16409 Wei et al. (1994)
Reverse GCTGCTGCTGTGGTCTTGGTC
Sequence, expected product length of the amplificate, and gene accession code (http://www.ncbi.nlm.nih.gov) of the primers used. RT-PCR,
reverse transcription polymerase chain reaction.
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Results
RT-PCR detection of nicotinic receptor
subunits in rat colonic epithelium
To determine which of the nicotinic receptor subunits are
expressed by rat colonic epithelium, RT-PCR was per-
formed using mRNA from isolated crypts, that is, epithe-
lial cells devoid of neuronal contamination, as starting
material. Skeletal muscle was used as positive control for
a1- and b1-subunit, for all the other subunits spinal cord
served as positive control. The following subunits were
consistently (in each of n ≥ 3 independent assays for each
mRNA) detected in colonic epithelial cells: a2, a4, a5, a6,
a7, a10, and b4. The mRNA for b2 was only inconsis-
tently detected in two of five experiments (Fig. 1). Not
detectable in colonic epithelium, but in control tissues
were the a1-, a3-, b1-, and b3-subunits. The a9 subunit
was neither detectable in the positive control nor in the
colonic epithelium, although different primers from the
literature (Glowatzki et al. 1995; Hecker et al. 2009; Mi-
kulski et al. 2010; Schirmer et al. 2011) were tested (see
Discussion for possible reasons). Water controls without
template did not show any amplificates (Fig. 1).
Functional evidence for nicotinic receptors
in rat colonic epithelium
Ussing chamber experiments were performed with DMPP
(104 mol/L), a nicotinic receptor agonist (Tapper and
Lewand 1981), in order to investigate if there is func-
tional evidence for the expression of nicotinic receptors
in colonic epithelium. The experiments were carried out
on mucosa preparations of rat distal colon (i.e., in the
absence of the myenteric and the submucosal plexus) and
in the continuous presence of the neurotoxin tetrodo-
toxin (106 mol/L) in order to prevent effects of DMPP
(or nicotine) on enteric neurons of the mucosal plexus,
which is still present in these preparations (Bridges et al.
1986). DMPP induced a transient, tetrodotoxin-resistant
increase in Isc of 2.87  1.00 lEq/h per cm2 (n = 6;
Fig. 2A), which was suppressed, when the tissue was pre-
treated with the nicotinic receptor antagonist hexametho-
nium (105 mol/L, Fig. 2B).
The effect of DMPP was mimicked by nicotine (Fig. 3).
Nicotine evoked a concentration-dependent increase in Isc.
For lower agonist concentrations (<104 mol/L), the sero-
sal compartment was washed three times with the fivefold
chamber volume before the next concentration was admin-
istered. Due to an apparent desensitization of the Isc
response evoked by nicotine at higher concentrations, nico-
tine in concentrations ≥104 mol/L was administered only
once to the same tissue. A maximal response was evoked at
a concentration of 3 9 104 mol/L, which declined when
the concentration was elevated to 103 mol/L probably
reflecting desensitization as nicotinic receptors are well
known to possess the ability to transform into the desensi-
tized state after agonist binding without prior transition
into the activated state (Giniatullin et al. 2005).
Sensitivity of nicotinic receptor subunit-
specific inhibitors on the nicotine-induced
Isc
In order to further characterize the presumed epithelial
nicotinic receptor subunits functionally, the interference
of presumed subunit specific inhibitors with the secretory
response induced by nicotinic receptor stimulation was
Figure 1. RT-PCR detection of mRNA expression of nicotinic acetylcholine receptor subunits in isolated rat colonic crypts. The agarose gel shows
bands of cDNA fragments amplified using primers for a2 (154 bp), a4 (197 bp), a5 (146 bp), a6 (142 bp), a7 (446 bp), a10 (168 bp), b2
(116 bp), and b4 (300 bp). cDNA from spinal cord was used as positive, water instead of cDNA as negative control. The efficiency of RNA
isolation and cDNA synthesis was verified by GAPDH-specific primers (303 bp). Each RT-PCR reaction was performed in at least three independent
experiments. The mRNA for b2 was only inconsistently detected in two of five experiments, whereas the signals for the other nicotinic receptor
subunits depicted here were found consistently. Cry, colonic crypts; SC, spinal cord; RT-PCR, reverse transcription polymerase chain reaction;
GAPDH, glyceraldehyde-3-phosphate dehydrogenase.
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tested. Inhibitors used were as follows: a-bungarotoxin,
an inhibitor of a7, a8, and a9*-subunits, strychnine,
which inhibits a7, a8, a9a10-subunits, dihydro-b-eryth-
roidine, an inhibitor of, for example, a4b2 and a3b2 nic-
otinic receptors (for references to the inhibitors used, see
Chavez-Noriega et al. 1997; Wonnacott and Barik 2007),
and atropine, which (in concentrations higher than those
needed for muscarinic receptor blockade) has been
reported to inhibit, for example, a3b2, a3b4, a4b2, or
a4b4 nicotinic receptors (Parker et al. 2003). The prein-
cubation for 20 min with strychnine (105 mol/L) and
atropine (2.5 9 105 mol/L) significantly inhibited the
increase in Isc induced by nicotine (10
4 mol/L). In con-
trast, a-bungarotoxin (106 mol/L) or dihydro-b-eryth-
roidine (105 mol/L) were ineffective (Fig. 4). Even when
the tissue was pretreated for 60 min with a-bungarotoxin
(106 mol/L) to allow a better diffusion of this macro-
molecule to its presumed action sites, the nicotine-evoked
increase in Isc was unaffected, as it amounted to
6.53  1.39 lEq/h per cm2 (n = 6) in the absence and
7.27  1.36 lEq/h per cm2 (n = 6) in the presence of
this neurotoxin.
Characterization of nicotinic receptor-
induced anion secretion
In order to find out if the nicotine-induced Isc is due to
Cl secretion, anion substitution experiments were per-
formed. In the presence of Cl, nicotine (104 mol/L)
evoked an increase in Isc of 5.58  0.97 lEq/h per cm2
(n = 8, Fig. 5). However, after substitution of Cl on
both sides of the tissue with the impermeable anion glu-
conate, the increase in Isc was significantly reduced and
Figure 3. Concentration-dependent increase in Isc across mucosa
preparations from rat distal colon induced by serosal administration of
nicotine (in the presence of tetrodotoxin). Values are given as increase
in Isc (DIsc) above baseline just prior administration of the respective
nicotine concentration and are means (filled circles)  SEM (vertical
lines), n = 6–8.
Figure 4. Effects of inhibitors of nicotinic acetylcholine receptor
subunits on nicotine-evoked secretion. The Isc induced by nicotine
(104 mol/L, applied in the presence of tetrodotoxin) across colonic
mucosa preparations was tested either under control conditions (open
bars) or in the presence of different inhibitors of nicotinic
acetylcholine receptor subunits (solid bars). Inhibitors: dihydro-b-
erythroidine (DhbE; 105 mol/L), a-bungarotoxin (106 mol/L),
strychnine (105 mol/L), or (a high concentration of) atropine
(2.5 9 105 mol/L). Values are given as increase in Isc (DIsc) above
baseline just prior administration of nicotine and are means  SEM;
n = 5–6. *P < 0.05 vs. response evoked by nicotine in the respective
control series.
(B)(A)
Figure 2. Stimulation of epithelial nicotinic receptors evokes an increase in Isc. Dimethylphenylpiperazinium (DMPP, 10
4 mol/L) induces an
increase in Isc in the presence of tetrodotoxin (TTX; 10
6 mol/L) across mucosa preparations from rat distal colon (A), which was suppressed by
preincubation with hexamethonium (105 mol/L; B). Values are given as means (black symbols)  SEM (gray area), n = 6. Line interruptions are
caused by omission of time intervals in order to synchronize the tracings of individual records to the administration of drugs.
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only amounted to 0.86  0.33 lEq/h per cm2 (P < 0.05
vs. control, n = 8).
Classically, nicotinic receptors function as ionotropic
receptors mediating an influx of cations such as Na+ or
Ca2+. As an increase in the cytosolic Ca2+ concentration
is well known to induce epithelial Cl secretion (e.g., Di-
ener and Schultheiss 2002), we tested the dependence of
the epithelial nicotine response on the presence of serosal
Ca2+. In the nominal absence of serosal Ca2+, the tetrodo-
toxin-resistant Isc evoked by nicotine (10
4 mol/L) was
reduced by more than 80% compared to the control
group, where nicotine was administered in the presence
of Ca2+ (n = 8, P < 0.05 vs. response in the presence of
Ca2+, Fig. 5). One of the central enzymes involved in
Ca2+-signaling cascades is calmodulin. In order to test the
involvement of this protein in the nicotine response, two
chemically different calmodulin inhibitors were used, that
is, trifluoperazine (e.g., Kleene 1994) and calmidazolium
(Worell and Frizzell 1991). Both inhibitors significantly
reduced the nicotine-evoked increase in Isc by more than
80% (P < 0.05 for both drugs, Fig. 5).
Choline induces an increase in Isc in a
concentration-dependent manner
Acetylcholinesterase has been detected in mucosal scrap-
ings of the large intestine of different mammals (Sine
et al. 1988), and the end product of the esterase reaction,
choline, is known to exert affinity for different nicotinic
receptors (Alkondon et al. 1997; Alkondon and Albuquer-
que 2006). In order to test the ability of the colonic epi-
thelium to cleave acetylcholine and thus produce choline,
which might potentially act at nicotinic receptors within
the tissue, an enzyme-histochemical staining for acetyl-
cholinesterase was performed. As can be seen in Figure 6,
the colonic epithelium expresses an acetylcholinesterase
activity. The reaction product was observed all over the
crypt axis, especially in the middle part of the crypts.
Thus we asked the question whether choline might
stimulate nicotinic receptors in the colonic wall. As not
only the epithelium (Fig. 6) but also enteric nerves (Mes-
tres et al. 1992) express high acetylcholinesterase activity,
choline might be produced in close vicinity of enteric
neurons, too. Therefore, for the Ussing chamber experi-
ments with choline, a mucosa–submucosa preparation
was used with an intact submucosal plexus in order not
to overlook possible effects of choline at neuronal nico-
tinic receptors. Choline (103 mol/L to 102 mol/L)
evoked a concentration-dependent increase in Isc (Fig. 7).
Because a strong desensitization was observed after
repeated administration of the agonist to the same tissue
(data not shown), choline was administered only once to
the same tissue. Desensitization might also explain why
the Isc response declined at the highest concentration
tested in the concentration–response curve experiments
(Fig. 7).
Sensitivity of the choline response to
tetrodotoxin and cholinergic antagonists
In order to investigate a possible contribution of secreto-
motor enteric neurons to the increase in Isc induced by
choline, the tissue was pre-incubated with tetrodotoxin
(106 mol/L). However, in the presence of this neuro-
toxin, choline (7.5 9 103 mol/L) induced an increase of
0.36  0.06 lEq/h per cm2 (n = 6), which was not differ-
ent from the increase in Isc evoked under control condi-
tions, which amounted to 0.38  0.10 lEq/h per cm2
(n = 6). Consequently, choline does not act via stimula-
tion of neuronal cholinergic receptors.
The inhibition of nicotinic receptors with hexametho-
nium (104 mol/L) did not affect the choline-induced Isc
(Fig. 8). However, atropine, used in a low concentration
(106 mol/L) that can be expected to selectively inhibit
muscarinic (and not nicotinic) receptors, reduced the
choline response significantly (P < 0.05 vs. control
response in the absence of any inhibitor; n = 6; Fig. 8).
In murine colonic epithelium, the two isoforms M1
and M3 of the muscarinic receptors have been described
(Haberberger et al. 2006). In order to find out, whether
M1 receptors were involved, the effect of choline was
Figure 5. Nicotine induces a Ca2+-dependent Cl secretion. The Isc
induced by nicotine (104 mol/L, applied in the presence of
tetrodotoxin) across mucosa preparations from rat distal colon was
either tested under control conditions (open bars) or after ion
substitution or in the presence of different inhibitors of the Ca2+
signaling pathway, respectively (solid bars). For the Cl-free solution,
Cl was removed from the serosal and the mucosal compartment, for
the Ca2+-free solution, Ca2+ was removed from the serosal
compartment. Inhibitors: trifluoperazine (5 9 105 mol/L) and
calmidazolium (5 9 107 mol/L). Values are given as increase in Isc
(DIsc) above baseline just prior administration of nicotine and are
means  SEM; n = 6–10. *P < 0.05 vs. response evoked by nicotine
in the respective control series.
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tested in the absence or presence of pirenzepine or tele-
nzepine, two M1 muscarinic receptor antagonists (Ham-
mer and Giachetti 1980; Galvan et al. 1989). Telenzepine
(107 mol/L) tended to reduce the choline-induced Isc as
did pirenzepine (106 mol/L, Fig. 8). However, these
effects did not reach statistical significance. A significant
inhibition, however, was observed, when the tissue was
pretreated with darifenacin or J104129 (Fig. 8), which
inhibit M3 muscarinic receptors (Mitsuya et al. 1999; Zin-
ner 2007). It can therefore be concluded that the choline-
induced secretion is due to an activation of muscarinic
receptors, particularly of the M3 subtype. Expression of
both M1 and M3 muscarinic receptors in isolated rat
colonic crypts was confirmed by RT-PCR experiments
(Fig. 9).
In rat brain, the low-affinity stimulation of a7 nicotinic
receptors by choline is thought to play mainly a modula-
tory role, as low concentrations of choline lead to a
desensitization of the corresponding receptors (Alkondon
et al. 1997). In order to investigate, whether a similar
desensitization of cholinergic receptors might occur at
colonic epithelium, tissues were desensitized to choline by
three consecutive administrations of this agonist
(103 mol/L). Indeed, the Isc evoked by a subsequent
administration of acetylcholine (103 mol/L) was signifi-
cantly attenuated compared to an untreated control
(Fig. 10). A pretreatment with choline reduced not only
the amplitude of the Isc response, but also shortened the
duration of the response (quantified as increase in Isc
above baseline 10 min after administration of acetylcho-
line) significantly (P < 0.05). The desensitization of the
acetylcholine response by choline was concentration-
dependent (Table 2).
Ionic nature of the Isc response to choline
Replacing Cl in the buffer solution by the impermeant
anion gluconate reduced the Isc evoked by choline
(7.5 9 103 mol/L) by 75% (n = 7–8, P < 0.05, Table 3).
A similar inhibition was observed in the presence of bu-
metanide (104 mol/L), an inhibitor of the Na+-K+-2Cl
cotransporter responsible for the basolateral uptake of
Cl during Cl secretion (n = 7–8, P < 0.05, Table 3).
Thus the choline-induced Isc is mediated by Cl
 secre-
tion.
Discussion
This study shows that nicotinic receptors are expressed in
colonic epithelial cells and that a stimulation of these
receptors induces an anion secretion across colonic epi-
thelium. The nicotinic agonist DMPP induces a transient
(B)(A)
Figure 6. Histochemical detection of acetylcholinesterase activity in rat colonic epithelium. (A) Lower part: muscularis propria; upper part: surface
area of the colonic epithelium. For the negative control (B), acetylthiocholine in the incubation medium was omitted. Typical results from three
independent experiments; scale bars: 50 lm.
Figure 7. Concentration-dependent increase in Isc across mucosa–
submucosa preparations from rat distal colon induced by serosal
administration of choline (filled circles, black solid line), Because of a
desensitization, each tissue was treated with only one concentration
of choline. Values are given as increase in Isc (DIsc) above baseline just
prior administration of the respective agonist concentration and are
means (symbols)  SEM (vertical lines), n = 6.
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increase in Isc across mucosa preparations, that is, prepa-
rations devoid of the submucosal and the myenteric
plexus. In order to prevent effects of DMPP on enteric
neurons of the mucosal plexus, the experiments were car-
ried out in the continuous presence of the neurotoxin
tetrodotoxin, suppressing the propagation of action
potentials. The response to DMPP was inhibited by a
preincubation with hexamethonium (Fig. 2) supporting
the assumption that there are functional nicotinic recep-
tors on the colonic epithelium. Also another agonist at
nicotinic receptors, nicotine itself, induced a concentra-
tion-dependent increase in Isc (Fig. 3), which was carried
by a Ca2+-dependent Cl secretion (Fig. 5). Classically,
nicotinic receptors function as ionotropic receptors
mediating an influx of cations such as Na+ or Ca2+. An
increase in the cytosolic Ca2+ concentration is well known
Figure 8. Effects of acetylcholine receptor antagonists on Isc induced by choline across colonic mucosa–submucosa preparations. The response to
choline (7.5 9 103 mol/L except the initial series with hexamethonium, where a concentration of 5 9 103 mol/L was used) was either tested
under control conditions (open bars) or in the presence of different inhibitors of acetylcholine receptors (solid bars). Inhibitors: hexamethonium
(104 mol/L), atropine (106 mol/L), telenzepine (107 mol/L), pirenezepine (106 mol/L), darifenacine (106 mol/L), and J104129 (5 9 106 mol/
L). Values are given as increase in Isc (DIsc) above baseline just prior administration of choline and are means  SEM; n = 6–8. *P < 0.05 vs.
response evoked by choline in the respective control series.
Figure 9. RT-PCR detection of mRNA expression of muscarinic M1 and M3 acetylcholine receptor subunits in isolated rat colonic crypts. The
agarose gel shows bands of cDNA fragments amplified using specific primers for M1 (373 bp) and M3 receptors (434 bp). cDNA from spinal cord
was used as positive control. The efficiency of RNA isolation and cDNA synthesis was verified by using GAPDH-specific primers (303 bp).
Representative results from three independent experiments. Cry, colonic crypts; SC, spinal cord; RT-PCR, reverse transcription polymerase chain
reaction; GAPDH, glyceraldehyde-3-phosphate dehydrogenase.
(B)(A)
Figure 10. Choline desensitizes the tissue against acetylcholine. Acetylcholine (103 mol/L) induces a long-lasting increase in Isc across mucosa–
submucosa preparations under control conditions (A), which is desensitized by three prior administrations of choline (103 mol/L; B). Values are
given as means (symbols)  SEM (lines), n = 6–7. Line interruptions are caused by omission of time intervals in order to synchronize the tracings
of individual records to the administration of drugs. For statistics, see Table 2.
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to induce epithelial Cl secretion (e.g., Diener et al. 1989,
Diener and Schultheiss 2002).
The transient time course of secretion induced by nico-
tinic agonists is in agreement with the effect of other
Ca2+-dependent secretagogues. This is not only observed
for endogenous agonists such as acetylcholine (Fig. 10),
which are quickly degraded enzymatically (in this case by
the acetylcholine esterase expressed by the epithelium,
Fig. 6), as also the response to esterase-resistant acetyl-
choline derivatives (like carbachol) is only transient (Stra-
bel and Diener 1995). As the increase in the cytosolic
Ca2+ concentration evoked by Ca2+-dependent secreta-
gogues lasts much longer than the secretory response of
the epithelium (Diener et al. 1991), an active downregula-
tion of transporters involved in anion secretion is gener-
ally assumed, which might involve release of fatty acids
by activation of Ca2+-dependent phospholipase A2, which
then inhibits ion channels (Devor and Frizzell 1998), a
transactivation of receptors for epithelial growth factor
(Keely and Barrett 2003), or internalization of the Na+-
K+-Cl cotransporter (NKCC1) thus reducing basolateral
Cl uptake (Calvo Del Castillo et al. 2005).
The RT-PCR experiments showed the consistent
expression of various nicotinic receptor subunits, namely
a2, a4, a5, a6, a7, a10, and b4, whereas the b2 subunit
transcripts were found only in a part (40%) of the sam-
ples (Fig. 1). For the a9 subunit, no amplification prod-
uct was detected neither in the control tissue nor in the
colonic epithelium. Mikulski et al. (2010) also described
problems with the detection of the a9 subunit in rat alve-
olar macrophages. They were able to detect the a9 sub-
unit only when using the Superscript II (Life
Technologies, Darmstadt, Germany) reverse transcriptase
system (for discussion of possible reasons, see Mikulski
et al. 2010). However, even with this method to prepare
cDNA from isolated crypts (and other tissues such as
skin, urothelium or spinal cord), we were unable to detect
a transcript (data not shown), which might indicate a low
stability of the corresponding mRNA. A proof of these
mRNA expression patterns on the protein level was not
possible due to the lack of suitable antibodies (e.g., Moser
et al. 2007). However, in accordance with our observa-
tions at native colonic epithelium, transcripts of various
nicotinic receptor subunits (i.e., a4, a5, a7, and b1) have
been detected by RT-PCR in the human colonic epithelial
tumor cell line HT29 and shown to be involved in
cytokine release (Summers et al. 2003) and cell prolifera-
tion (Wong et al. 2007).
Theoretically, the expression of the nicotinic receptor
subunits found (Fig. 1) would enable the formation of
several nicotinic receptor subtypes such as homopenta-
meric a7 or heteromers of a2b4, a4b4, and a5a7b4. For
investigating the functional significance of the nicotinic
receptor subunits expressed, we performed experiments
with selective antagonists of different nicotinic receptor
Table 3. Choline-induced Isc is carried by Cl
 secretion.
Conditions
Choline-induced increase
in Isc (DIsc; lEq/h per cm
2) n
With chloride 1.25  0.30 7
Without chloride 0.30  0.19* 8
Without bumetanide 0.64  0.18 7
With bumetanide 0.15  0.03* 8
Chloride dependency of the Isc response evoked by choline
(7.5 9 103 mol/L) across mucosa–submucosa preparations from rat
distal colon. For each experimental series, the response to choline was
tested in the presence of bumetanide (104 mol/L) or after chloride
substitution (at the mucosal and serosal side), respectively, and com-
pared to the response under control conditions. Values are given as
increase in Isc above baseline just prior to administration of choline
(DIsc) and are means  SEM.
*P < 0.05 vs. response evoked by choline in the respective control ser-
ies.
Table 2. Choline desensitizes the tissue against acetylcholine.
Conditions
Acetylcholine-induced increase in Isc
nPeak (DIsc; lEq/h per cm
2) Plateau (DIsc; lEq/h per cm
2)
No choline 10.96  0.97 3.13  0.81 6
103 mol/L choline 6.68  1.56* 0.58  0.42* 6
No choline 9.88  1.68 2.40  0.97 6
5 9 104 mol/L choline 7.50  1.39 2.34  1.31 7
No choline 8.88  1.73 1.47  0.92 6
104 mol/L choline 10.34  1.42 2.52  0.80 6
Increase in Isc evoked by acetylcholine (10
3 mol/L) across mucosa–submucosa preparations from rat distal colon under control conditions (“no
choline”) or after pretreatment with three different concentrations of choline (administered three times in intervals of 15 min). Both the maximal
increase in Isc (peak) as well as the long-lasting rise in Isc (measured 10 min after administration of acetylcholine) are given. Values are given as
increase in Isc above baseline just prior to administration of acetylcholine (DIsc) and are means  SEM.
*P < 0.05 vs. response evoked by acetylcholine in the respective control series.
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subunits. The preincubation of the tissue with dihydro-b-
erythroidine, a potent inhibitor of, for example, a4b2 and
a3b2 nicotinic receptors (Chavez-Noriega et al. 1997;
Wonnacott and Barik 2007), as well as a preincubation
with a-bungarotoxin, an inhibitor of a7, a8, and a9*
receptors, did not affect the increase in Isc evoked by nic-
otine (Fig. 4). In contrast, the nicotine response was sig-
nificantly inhibited after a preincubation with the a7, a8,
a9/a10 receptor antagonist strychnine or atropine
(Fig. 4). Atropine, although being the classical antagonist
of muscarinic receptors, is known since long to inhibit –
at higher concentrations – nicotinic receptors, too (Am-
bache 1955), an effect, which can also be seen on the level
of acetylcholine- or nicotine-evoked inward currents at
Xenopus oocytes heterologously expressing human nico-
tinic receptors (Zwart and Vijverberg 1997). Atropine has
been reported to inhibit, for example, a3b2, a3b4, a4b2,
or a4b4 receptors (Parker et al. 2003). This might – at
first glance – allow different combinations of functional
strychnine-sensitive (e.g., a10*) or atropine-sensitive (e.g.,
a4b4) epithelial nicotinic receptors when combining the
inhibitor experiments (Fig. 4) with the expression data
(Fig. 1). However, the observed inhibitor profile differs
from classical observations obtained with nicotinic recep-
tor subunit combinations from excitable tissues in two
aspects. Usually, strychnine (blocker of a7, a8, a9a10-su-
bunits) and a-bungarotoxin (blocker of a7, a8, and a9*-
subunits) have a similar pharmacological profile, but at
rat colonic epithelium only strychnine was an effective
inhibitor. Furthermore, after heterologous expression of
the corresponding human subunits in Xenopus oocytes,
the atropine-sensitive heteromer a4b4 is highly sensitive
to dihydro-b-erythroidine, which also proved to be with-
out effect at rat colonic epithelium (Fig. 4). Whether spe-
cies differences or variations in the subunit combinations
of nicotinic receptors between excitable and nonexcitable
cells are responsible for this discrepancy, finally remains
open. Furthermore, strychnine might have other effects
such as, for example, the inhibition of glycine receptors,
where strychnine acts as a classical antagonist (e.g., Gren-
ningloh et al. 1987). Nevertheless, the observation that
hexamathonium abolishes the tetrodotoxin-resistant
increase Isc evoked by nicotinic agonists (Fig. 2) together
with the expression data on mRNA level (Fig. 1) clearly
shows a functional role of epithelial nicotinic receptors,
although their subunit stoichiometry remains undefined.
A further unexpected result of this study was the obser-
vation that choline has the ability to act as an agonist of
epithelial muscarinic receptors and thereby induces a Cl
secretion across the colonic epithelium (Fig. 7, Table 3).
Choline is a cleavage product of the hydrolysis of acetyl-
choline by acetylcholinesterases. Mucosal intestinal scrap-
ings from various mammals are known to express high
cholinesterase activity (Sine et al. 1988). This study
confirmed the expression of cholinesterase in rat colonic
epithelium by histochemical staining demonstrating
high cholinesterase activity all over the crypt axis
(Fig. 6). Since the histochemical assay was performed
without addition of iso-tetraisopropylpyrophosphoramide
(OMPA) (due to its high toxicity), a specific inhibitor of
the butyrylcholinesterase (Koelle et al. 1973), it is not
possible to differentiate if the reaction product is due to
an acetylcholinesterase or butyrylcholinesterase activity.
Choline is well known for its affinity to some nicotinic
receptors. For example, choline has been described as full
agonist of a7 nicotinic receptors in rat neurons and as
partial agonist of nicotinic receptors containing a3b4* su-
bunits (Alkondon et al. 1997). In contrast, on nicotinic
a4b4* receptors choline acts as an antagonist (Alkondon
and Albuquerque 2006). Thus, we had expected that – if
choline might be able to induce changes in electrogenic
ion transport – the response to choline would be
mediated by a stimulation of the nicotinic receptors
found in the functional (Figs. 2–4) and RT-PCR (Fig. 1)
experiments. However, although choline induced a
tetrodotoxin-resistant Cl secretion across rat colonic
epithelium, this effect was unaffected by hexamethonium
(Fig. 8). In contrast, the choline-induced Isc was inhibited
by the nonselective muscarinic antagonist atropine
(Fig. 8). Because M1 as well as M3 muscarinic receptors
have been described to be expressed in murine colonic
epithelium (Haberberger et al. 2006), the effect of choline
was tested in the presence of specific antagonists of M1 or
M3 acetylcholine receptors. Inhibition of M3 muscarinic
receptors with darifenacin or J104129 significantly inhib-
ited the increase in Isc evoked by choline (Fig. 8). Thus
choline induces an activation of epithelial muscarinic
receptors in rat distal colon resulting in a Cl secretion.
Although choline is well known for its affinity to nicotinic
receptors (see above), in the literature at least in one tis-
sue muscarinic effects of choline have been described, that
is, the stimulation of muscarinic receptors on atrial myo-
cytes from canine and guinea pig heart (Shi et al. 1999).
The physiological relevance for direct stimulation of
muscarinic epithelial receptors by choline, the degradation
product of acetylcholine, is probably low. Millimolar con-
centrations of choline are required to induce an increase
in Isc and even at the highest concentration used
(102 mol/L) only a small secretory response was evoked
by this agonist (Fig. 7), suggesting that choline might act
only as partial agonist. Furthermore, considering, for
example, the physiological plasma concentration of cho-
line, which amounts to about 10 lmol/L in humans (Zei-
sel 2000), it is quite improbable that millimolar
concentrations are reached in vivo, although the cleavage
of acetylcholine by esterases might transiently result in
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higher local concentrations of choline. However, for the
action of choline at a7 nicotinic receptors in rat brain, a
modulatory role of low concentrations of choline has
been proposed, as these concentrations lead to a desensiti-
zation of the corresponding receptors (Alkondon et al.
1997). A similar desensitization by choline of the acetyl-
choline-induced Isc was observed in the colonic epithe-
lium (Fig. 10), suggesting that in vivo the degradation
product of acetylcholine might well be able to modify
cholinergic signaling to the epithelium.
Taken together the present experiments reveal a more
complex cholinergic regulation of epithelial ion transport
in colonic mucosa than previously thought. Acetylcholine,
produced both by enteric neurons (Harrington et al.
2010) as well as by the colonic epithelium (Klapproth
et al. 1997; Bader et al. 2014) modulates anion secretion
both by epithelial muscarinic and by epithelial nicotinic
receptors and also its degradation product, choline, is able
to modify cholinergic transmission.
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